CompletedNot Applicable

Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Egypt100 participantsStarted 2023-04-15

Plain-language summary

Warts are common epidermal growths caused by various strains of human papilloma virus (HPV). Viral warts are common with a prevalence rate of 7-12%. Human papilloma virus is small non enveloped viruses that contain a double-stranded DNA genome. There are more than 200 HPV genotypes are reported, however, the high-risk types, including HPV genotype-16 (HPV16), 18, 31, and 45, are the causes of 80% of cervical cancers.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The study will include patients with cutaneous warts of various types aged 18-50 years old. Exclusion Criteria: * 1\. Pregnancy 2. Lactation 3. Patient on anti-inflammatory and antioxidant drugs 4. Skin infections, other than warts 5. Skin diseases 6. Systemic infection. 7. Malignancies

What they're measuring

This study aims to assess the expression of genes of SOCS3 in cutaneous warts.

Timeframe: from april 2023 to December 2023

This study aims to assess the expression of genes of IFN-α in cutaneous warts.

Timeframe: from April 2023 to December 2023

This study aims to assess the expression of genes of IFN-β in cutaneous warts.

Timeframe: from April 2023 to December 2023

Trial details

NCT IDNCT05781841

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Warts trials